Publications by authors named "Roderau Outh"

Claim this Profile
D
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.
Romain Stammler, Alexandre Vallée, Julien Rohmer, Nathalie Grardel, Noémie Abisror, Roderau Outh

J Allergy Clin Immunol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.
Paul Breillat, Francesco Carbone, Emilie Lereclus, Quentin Riller, Thibaut d'Izarny-Gargas, Rodérau Outh

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.
Vincent Jachiet, Olivier Kosmider, Maxime Beydon, Jérôme Hadjadj, Lin-Pierre Zhao, Roderau Outh

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study.
Adrien Cottu, Laure Delaval, Alexandra Forestier, Alessandro Tomelleri, Corrado Campochiaro, Roderau Outh

Rheumatology (Oxford)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Neurological manifestations in patients with VEXAS syndrome.
Charlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, Benoit Faucher, Rim Bourguiba, Roderau Outh

J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Guillaume Lefèvre, Séverine Bleuse, Mathieu Puyade, Guillaume Moulis, Antoine Néel, Roderau Outh

Allergy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological manifestations in patients with VEXAS syndrome.
Charlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, Benoit Faucher, Rim Bourguiba, Roderau Outh

J Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.
Sophie Nagle, Yann Nguyen, Mary-Jane Guerry, Thomas Quemeneur, Dimitri Titeca-Beauport, Roderau Outh

Ann Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Jerome Hadjadj, Yann Nguyen, Dalila Mouloudj, Rim Bourguiba, Mael Heiblig, Roderau Outh

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
Benjamin de Valence, Marion Delaune, Yann Nguyen, Vincent Jachiet, Mael Heiblig, Roderau Outh

Ann Rheum Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Olivier Kosmider, Céline Possémé, Marie Templé, Aurélien Corneau, Francesco Carbone, Roderau Outh

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases.
Ève Zakine, Loula Papageorgiou, Rim Bourguiba, Arsène Mekinian, Benjamin Terrier, Rodérau Outh

J Am Acad Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
Raphael Borie, Marie Pierre Debray, Alexis F Guedon, Arsene Mekinian, Louis Terriou, Roderau Outh

Chest· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
Roderau Outh, Caroline Boutin, Philippe Gueudet, Marcelino Suzuki, Matthieu Saada

J Microbiol Immunol Infect· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapses in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective study.
Roderau Outh, Anne Lemaire, Alexandre Mania, Pauline Berland, Laurent Gerbaud

Clin Rheumatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis